Our models are not intended to predict the probability of the three cancers among women known to be at much higher than average risk, e.g., women with a mutation in BRCA1 or BRCA2 or with hereditary non-polyposis colorectal cancer (HNPCC). This evidence concerns the gene BRCA2 and hereditary nonpolyposis colon cancer.